Daewoong Pharmaceutical announced that they received approval of NABOTA from Thai Food and Drug Administration last month

Published: 2014-06-11 12:04:30

Updated: 2014-06-11 12:04:30

On June 9, Daewoong Pharmaceutical announced that they received approval of NABOTA from Thai Food and Drug Administration (TFDA) last month.

The company plans to conduct a launching symposium targeting 300 experts and VIPs in Thailand starting from coming August, and plans to expand its market share in earnest through developing a variety of cosmetic procedure and reflecting the needs of consu...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.